MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Tissue-engineered nigrostriatal pathway to rebuild dopaminergic axons in Parkinson’s disease based on clinical design criteria

    W. Gordián Vélez, D. Chouhan, H I. Chen, J. Duda, D K. Cullen (Philadelphia, USA)

    Objective: To create a tissue-engineered construct with the dopaminergic (DA) cell numbers, axon lengths, and functionality required to reconstruct the human nigrostriatal pathway (NSP). Background:…
  • MDS Virtual Congress 2021

    Both online and in-person JOBGRIP group training for people with Parkinson’s with paid employment is acceptable and perceived to be valuable

    I. Sturkenboom, J. Vanomme-Vanlaarhoven, M. Noordegraaf, B. Bloem (Nijmegen, Netherlands)

    Objective: Explore acceptability and perceived efficacy of a group intervention for people with Parkinson’s diseases (PD) with paid employment. Background: PD leads to changes in…
  • MDS Virtual Congress 2021

    Is the association between cigarette smoking and Parkinson disease causal? A Mendelian Randomization study.

    C. Domenighetti, PE. Sugier, A. Ashokkumar Sreelatha, C. Schulte, S. Grover, O. Mohamed, B. Portugal, P. May, D. Bobbili, M. Radivojkov-Blagojevic, P. Lichtner, R. Krüger, T. Gasser, M. Sharma, A. Elbaz (Villejuif Cedex, France)

    Objective: To determine whether the association between cigarette smoking and Parkinson disease (PD) is causal using 2-sample Mendelian randomization (MR) and to examine the potential…
  • MDS Virtual Congress 2021

    Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up

    C. Simonet, A. Gill, J. Bestwick, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2021

    Parkinson’s disease and Post-COVID-19 syndrome

    V. Leta, M. Rodríguez-Violante, A. Abundes, K. Rukavina, J. Teo, C. Falup-Pecurariu, L. Irincu, S. Rota, R. Bhidayasiri, A. Storch, P. Odin, A. Antonini, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To report the prevalence of Post-Corona Virus Disease 2019 (COVID-19) syndrome in a case series of Parkinson’s disease (PD) patients. Background: Implications of COVID-19…
  • MDS Virtual Congress 2021

    WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Baseline Analyses

    J. Adams, E. Dorsey, T. Ruiz Herrero, P. Auinger, R. Alexander, R. Rubens, B. Tracey, N. Zach, P. O'Donnell, A. Best, J. Severson, M. Kostrzebski, E. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Fisher, J. Edgerton, T. Kangarloo (Rochester, USA)

    Objective: To provide a profile of early Parkinson’s disease (PD) using clinical and digital measures and determine whether digital measures can differentiate PD and controls…
  • MDS Virtual Congress 2021

    Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To investigate satisfaction with daily remote monitoring with a digital health technology tool (DHTT) in individuals with early Parkinson’s disease (PD) and the relationship…
  • MDS Virtual Congress 2021

    Climb up! Head up! Effectiveness and feasibility of sport climbing in Parkinson’s disease

    A. Langer, H. Zach, S. Hasenauer, A. Flotz, L. Gassner, R. Pokan, P. Dabnichki, L. Wizany, D. Roth, S. Zimmel, M. Treven, M. Schmoeger, U. Willinger, W. Maetzler (Wien, Austria)

    Objective: The current study examines the effectiveness and feasibility of sport climbing in PD patients in a single-centre, randomised controlled, semi-blind trial. Background: Physical activity…
  • MDS Virtual Congress 2021

    Feasibility of dance therapy through synchrony videoconference in Parkinson’s disease and elderly people.

    C. Pinto, C. Figueiredo, V. Mabilia, I. Cortez, F. Pereira, T. Rosa, I. Bevilacqua, E. Jeffrey, A. Pagnussat (Porto Alegre, Brazil)

    Objective: To investigate the safety and effectiveness of online dance classes (in live) in a group of people with and without Parkinson's Disease. Background: Dance…
  • MDS Virtual Congress 2021

    CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform

    E. Berkovich (Petch-Tikva, Israel)

    Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…
  • « Previous Page
  • 1
  • …
  • 426
  • 427
  • 428
  • 429
  • 430
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley